CTRI/2014/08/004894
Not yet recruiting
Phase 2
A Study To Establish The Standard Treatment Protocol For Parkinsons Disease(Kampavata)
IPGT And RA Gujarat Ayurved University Jamnagar0 sites10 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Patients suffering from Parkinsons disease
- Sponsor
- IPGT And RA Gujarat Ayurved University Jamnagar
- Enrollment
- 10
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1 Patients fulfilling the diagnostic criteria.
- •2 Patients who are willing and able to participate in the study.
Exclusion Criteria
- •1 Repeated strokes with stepwise progression
- •2 Repeated head injury
- •3 Definite encephalitis
- •4 More than one affected relative.
- •5 Presence of cerebral tumour
- •6 Patients with uncontrolled Diabetes Mellitus and having a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in last 6 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A study to establish the standard procedure using ICG lymphography for lymphedema.lymphedemaJPRN-UMIN000018719Department of Plastic and Reconstructive Surgery, Okayama University100
Active, not recruiting
Not Applicable
STANDARD-Study -- Standardized Treatment and Diagnostic Approach to Reduce Disease burden in the early post-operative phase in children with congenital heart defectsQ20-Q28Congenital malformations of the circulatory systemDRKS00025430niversitätsklinikum des Saarlandes74
Completed
Phase 1
The clinical standardization study on the treatment of spleen deficiency syndrome after repeated respiratory tract infection by the method of cultivating earth to generate goldSpleen deficiency syndrome after recurrent respiratory tract infection in childrenITMCTR2100004923Children's Hospital of Shanghai
Active, not recruiting
Not Applicable
Standardized clinical trial on the application of Levodopa (LD) / Carbidopa (CD) to patients with Parkinson disease vs LD / CD and Entacapon (EN) vs LD / CD and Tolcapon (TO) concerning the parameters motor function, pharmacokinetics of LD, plasma level of homocystein and serum level of cortisol.Male and female patients with Parkinson´s disease meeting UKPDS criteriaMedDRA version: 12.1Level: LLTClassification code 10013113Term: Disease Parkinson'sEUCTR2009-017416-33-DEClinical research lab for neurodegeneration, Dept. of Neurology, St. Josef-Hospital, Ruhr-University
Completed
Not Applicable
Evaluation of the treatment standard: Treatment of severe acute lung injury by extracorporeal membrane oxygenatiosevere acute respiratory distress syndromeDRKS00013967niversitätsmedizin Mannheim24